EXHIBIT 99.1

JOINT FILER INFORMATION

Title of Derivative Securities: Series C Convertible Preferred Stock

Issuer & Ticker Symbol: KaloBios Pharmaceuticals, Inc.

Date of event requiring statement: August 11, 2012

Designated Filer:

Lehman Brothers Holdings Inc.

1271 Avenue of the Americas

New York, NY 10020

Other Joint Filer Information:

Lehman ALI Inc., a Delaware corporation, a direct wholly-owned subsidiary of the Reporting Person and direct 100% parent of LB I Group Inc.

1271 Avenue of the Americas

New York, NY 10020

LB I Group Inc., a Delaware corporation, a direct wholly-owned subsidiary of Lehman ALI Inc.

1271 Avenue of the Americas

New York, NY 10020

Signatures of Joint Filers:

LEHMAN ALI INC.
/s/ William Fox
Name:	William Fox
Title:	Executive Vice President and Chief Financial Officer

LB I GROUP INC.
/s/ William Fox
Name:	William Fox
Title:	Executive Vice President and Chief Financial Officer